| Biliary Disease |
1 |
1 |
| Hepatocellular Carcinoma |
0 |
0.9 |
| Liver |
0 |
0.6 |
| Non-Alcoholic Fatty Liver Disease |
0 |
0.57 |
| Liver Disease |
0 |
0.55 |
| Noncolorectal Gastrointestinal Cancer |
0 |
0.51 |
| Fatty Liver |
0 |
0.48 |
| Primary Sclerosing Cholangitis |
0 |
1 |
| Liver Biopsy |
0 |
0.45 |
| Diagnostic Liver Biopsy |
0 |
0.44 |
| Genomic Medicine |
0 |
0.44 |
| Cholangitis |
0 |
0.43 |
| Cholangiocarcinoma |
0 |
0.34 |
| Pathogenesis |
0 |
0.34 |
| Inflammatory Bowel Disease |
0 |
0.26 |
| Cancer |
0 |
0.17 |
| Autoimmune Disease |
0 |
0.09 |
| Biliary Tract |
0 |
0.09 |
| Biopsy |
0 |
0.09 |
| Body Mass Index |
0 |
0.09 |
| Cirrhosis |
0 |
0.09 |
| Diarrhea |
0 |
0.09 |
| Gastroenteritis |
0 |
0.09 |
| Hospital |
0 |
0.09 |
| Imbalance |
0 |
0.09 |
| Medical Literature |
0 |
0.09 |
| Prognosis |
0 |
0.09 |
| Receptors |
0 |
0.09 |